CCMB study uncovers new way to stop fatal fungal infection from turning deadly

Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad have identified a previously unknown weakness in Cryptococcus neoformans, a deadly fungal pathogen. This discovery could lead to new strategies to combat cryptococcal disease, which causes hundreds of thousands of deaths worldwide each year.

The research, led by Dr. Sriram Varahan, focuses on the fungus's ability to form giant cells called 'Titan cells'. These oversized cells help the fungus dodge the body's immune system. By understanding and potentially blocking the processes that trigger Titan cell formation, the researchers believe it may be possible to weaken the fungus, improve immune clearance, and reduce the severity of cryptococcal meningitis.

Cryptococcal meningitis is a serious infection that affects more than 1.5 lakh people globally each year, including thousands in India. It has a high mortality rate, especially among people with weakened immune systems, such as those living with HIV/AIDS. Unlike many fungal infections that stay on the skin, Cryptococcus typically enters through the lungs and can spread via the bloodstream to the brain.

Most fungal cells are only a few micrometres in diameter, but some can enlarge into Titan cells. These giant cells are too large for immune cells to engulf and destroy effectively. This allows the fungus to evade the body's defences, survive for long periods, and cause persistent, life-threatening infections.

The CCMB team discovered a new biological circuit that links the fungus's energy metabolism to a key cellular signalling system. This connection enables Titan cell formation. Traditionally, metabolism has been seen simply as the way cells generate energy. However, this study reveals that metabolism also acts as a regulatory system, influencing whether the fungus transforms into its more dangerous Titan-cell form.

Dr. Varahan explained, 'Our findings show that metabolism is not merely supplying fuel. It is actively controlling the cellular signals that allow the fungus to transform into Titan cells.'

The researchers found that calcium, which acts as a messenger inside cells, activates calcineurin. This is a master signalling pathway that helps the fungus survive stressful conditions inside the human body and develop into Titan cells. The study establishes, for the first time, a direct link between the fungus's energy metabolism and calcium signalling in controlling Titan cell formation. The two systems work together as a coordinated biological network, allowing the pathogen to adapt and thrive within its host.

This discovery has significant therapeutic potential. Instead of only trying to kill the fungus outright, future treatments could focus on preventing Titan cell formation. This would effectively disarm one of the pathogen's key disease-causing mechanisms before a severe infection sets in.

With invasive fungal pathogens causing hundreds of thousands of deaths annually and antifungal drug resistance on the rise, this finding offers a promising new direction for research. The study provides a fresh target for drug development, which could eventually save many lives, particularly in regions where cryptococcal meningitis is common.

The CCMB team's work is a step forward in understanding how a deadly fungus evades the immune system. It also highlights the importance of basic biological research in addressing global health threats. While new treatments based on this study are still a long way off, the findings open a new avenue for scientists working to fight fungal infections.